KATY GARNER: Open Payments
NPI 1821330424 · PULASKI, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$743 in 38 payments from 19 companies in 2025. Trend: 2023 $564 · 2024 $395 · 2025 $743
Food & beverage: $743
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 9 | $168 |
| Aimmune Therapeutics, Inc. | 4 | $81 |
| Vanda Pharmaceuticals Inc. | 2 | $62 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $55 |
| PFIZER INC. | 3 | $50 |
| E.R. Squibb & Sons, L.L.C. | 2 | $48 |
| Lundbeck LLC | 2 | $38 |
| ABBVIE INC. | 2 | $31 |
| Otsuka America Pharmaceutical, Inc. | 1 | $25 |
| Ardelyx, Inc. | 1 | $24 |
Products named: AIRSUPRA, ZENPEP, HETLIOZ, CAPLYTA, NURTEC ODT, COBENFY, VYEPTI, REXULTI.
Industry payments across TN — which companies pay providers there.
